individuals cope with this disease. In addition to better understand how to use existing drugs, in 2015 a new class of drugs called JAK 1/2 inhibitors emerged and appears promising. Also, the anti-IL17 antibody, secukinamab, appears to benefit patients with ankylosing spondylitis (AK) as well as psoriatric arthritis (PsA).

For prevention of joint erosion, a new drug combination shows promise for patients at risk of joint destruction, and the combination of Cimzia plus methotrexate significantly slows inflammation in the joints for patients with early RA who are at risk of poor prognosis. Studies continue to support “treat to target” and measures of disease activity like Vectra continue to be refined to guide physicians and patients toward optimal therapy. Looking ahead, researchers will be putting forth continued effort to understand the body’s immune system to create more targeted drugs for further management of this chronic and debilitating auto-immune disease.

RA News

• Prolia Prevents Joint Erosions in Rheumatoid Arthritis
• Oral Baricitinib Works Alone or as Combo RA Treatment
• Baricitinib Reduces Inflammation and Joint Damage in Rheumatoid Arthritis
• Are JAK-1 Inhibitors The Next Advancement for the Management of Rheumatoid Arthritis?
• Orencia® and Actemra® Are Similarly Effective in RA
• Cimzia® plus Methotrexate Slows Disease Progression in Early RA
• Baricitinib May Offer Treatment Options for RA Patients with Limited Options
• Stomach Bugs and Other Unpleasant Infections May Help Prevent RA
• Actemra® Effective in 80% of RA Patients Who Stay on Treatment for One Year
• Reduction in RA-Related Bone Inflammation Measureable on MRI after Four Months of Cimzia®
• Levels of Protein Interleukin-6 May Help Predict Progression in Early Rheumatoid Arthritis

Psoriatric Arthritis

• Tight Control Improves Control of Psoriatic Arthritis
• Secukinumab Wins in Psoriatic Arthritis
• Interleukin 6 Blockade Represents Promising Approach in Psoriatic Arthritis

Ankylosing Spondylitis

• Secukinamab: A New Class of Therapy for Ankylosing Spondylitis Patients
• Interleukin 6 Blockade Represents Promising Approach in Psoriatic Arthritis

Ask the Expert Web Chats

• Ask the Expert: How to Know if Your RA Treatment is Working
• Available Now: How to Track Your Rheumatoid Arthritis
• Available Now: Communicating with Your Doctor about RA

CURRENT RHEUMATOID ARTHRITIS NEWS

Knowledge is Power

Are you facing a new diagnosis of RA, suffering an RA flare, living with an auto-immune disease, or supporting a loved one through their RA journey?

• Sign up for monthly newsletters on RA here.
• Get support information for RA here.
• Join theRAConnection online support group to join ongoing discussions with other individuals affected by RA here.
• Follow theRAConnection on Facebook and Twitter.